The experience of treating chronic peri-implantitis in HIV positive patients

Abstract

Relevance. There is a scarcity of data regarding the treatment of chronic peri-implantitis in HIV-positive patients. The refinement of available techniques for managing inflammation around dental implants holds significant importance, particularly in individuals infected with HIV. Hence, this study aims to consolidate clinical experiences in managing chronic peri-implantitis in HIV-positive patients.Materials and methods. The study involved six male patients (treatment group), aged 35 to 54, diagnosed with chronic peri-implantitis, exhibiting inflammation around dental implants and testing HIV positive. These patients, under dynamic observation by their infectious disease specialist, were consistently receiving antiretroviral treatment. The control group consisted of 10 males aged 28 to 55, devoid of HIV or any other condition causing secondary immunodeficiency. Oral cavity microbiota and mucosal immunity were examined, and treatment for chronic peri-implantitis was administered. Both groups had dental implants for 5 to 7 years. The specifics of the implantation systems were not explored.Results. HIV-positive patients with peri-implantitis exhibited alterations in microbiota and mucosal immunity, correlating with "viral load" indicators. The study presented combined treatment outcomes for periodontitis and the influence of adjusted antiretroviral therapy on mucosal immunity and oral cavity microbiota parameters.Conclusion. Peri-implantitis onset in HIV-positive patients with adequate oral hygiene might be linked to an underlying factor involving ineffective administration of antiretroviral treatment. Consequently, diagnosing periimplantitis in HIV-positive individuals should not only entail appropriate therapeutic and preventive measures as part of a comprehensive peri-implantitis treatment regimen, along with precise oral hygiene correction performed professionally, but also timely referral to an infectious disease specialist for adjustment of antiretroviral therapy.